While ALP compounds, which are potential Akt inhibitors, affect cell survival signals in several cancer cell models [13], [15], [16], [17], it has not been tested if the ALP compounds also affect the cell survival signaling in HIV-1 infected cells. The gene discussed is AKT1; the disease is cancer.